文献
J-GLOBAL ID:201802225893406765
整理番号:18A0723910
境界ER陽性原発性乳癌は内分泌療法から有意な生存利益を得ない:系統的レビューとメタ分析【JST・京大機械翻訳】
Borderline ER-Positive Primary Breast Cancer Gains No Significant Survival Benefit From Endocrine Therapy: A Systematic Review and Meta-Analysis
著者 (7件):
Chen Tong
(Department of Breast Surgery, Qilu Hospital, Shandong University, Jinan, Shandong Province, People’s Republic of China)
,
Zhang Ning
(Department of Breast Surgery, Qilu Hospital, Shandong University, Jinan, Shandong Province, People’s Republic of China)
,
Moran Meena S.
(Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT)
,
Su Peng
(Department of Pathology, Qilu Hospital, Shandong University, Jinan, Shandong Province, People’s Republic of China)
,
Haffty Bruce G.
(Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ)
,
Yang Qifeng
(Department of Breast Surgery, Qilu Hospital, Shandong University, Jinan, Shandong Province, People’s Republic of China)
,
Yang Qifeng
(Pathology Tissue Bank, Qilu Hospital, Shandong University, Jinan, Shandong Province, People’s Republic of China)
資料名:
Clinical Breast Cancer
(Clinical Breast Cancer)
巻:
18
号:
1
ページ:
1-8
発行年:
2018年
JST資料番号:
W3206A
ISSN:
1526-8209
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)